Lanzhou Pharmaceutical New Area production base officially put into operation to promote the development of Longyao pharmaceutical industry

[chinapharma.com Pharmaceutical Engineering] on August 19, Lanzhou Pharmaceutical Co., Ltd held the launch ceremony of Lanzhou New Area production base It is reported that the production base is constructed in two phases The first phase has a total construction area of 3651181m2 and an investment of 630 million; the second phase has a planned investment of 406 million and a construction area of 22000 m2 The formal production of the new area production base has become a node sign of Gansu's revitalization of the real economy and going out of the city and into the park (the scene of the launch ceremony of the production base of Lanzhou Pharmaceutical New Area) on the occasion of the fifth anniversary of the establishment of Lanzhou New Area, it is the 59th birthday of Lanzhou pharmaceutical, an old pharmaceutical enterprise in Gansu Province On the morning of the 19th, Lanyao Pharmaceutical Co., Ltd held the launch ceremony of the new production base Song Baocai, deputy director of Gansu food and drug administration, attended the launch ceremony More than 200 experts, professors and representatives of medical businessmen from all over the country attended the launch ceremony Song Baocai, deputy director of the food and Drug Administration of Gansu Province, said that at present, the state is vigorously promoting the structural reform of the supply side of medicine, carrying out major reforms in the drug review and approval system, supporting drug research and development innovation, and taking the development of medicine as an important part of the healthy China strategy Gansu provincial Party committee and Gansu provincial government also attach great importance to the supervision and development of the pharmaceutical industry, and cultivate and develop the development of traditional Chinese medicine as a strategic pillar industry in Gansu Province Gansu has been approved as a comprehensive experimental area of traditional Chinese medicine industry, which will bring new development opportunities for the development of the industry The industry of traditional Chinese medicine is in this new development period, and the people of traditional Chinese medicine should seize the opportunities and create new brilliance Huang Song Baocai also said that the Gansu food and Drug Administration will always adhere to the same emphasis on supervision and service to ensure the development of pharmaceutical enterprises in Gansu Province It is hoped that Lanyao people will adhere to the concept of "quality", take quality and safety as the cornerstone of survival and development, continuously strengthen staff skills training, continuously improve research and development capabilities, continuously strengthen brand strategy research, and make greater contributions to the development of health care in the whole province and even the whole country Yang Jun, chairman of Beijing haijixing medical science and Technology Co., Ltd., introduced that the production base of Lanyao Pharmaceutical New Area will help complete the layout of the whole industry chain in China Together with Gansu Fuzheng Pharmaceutical Co., Ltd and Tibet Fuzheng Pharmaceutical Co., Ltd., we can set up from gap standardized planting base to GCP standardized clinical experiment, then to GMP standardized production, and finally through GSP flow Through the enterprise, we build the "Jetion medical strategy" We will continue to carry forward the "righting culture" which is "the essence of the collection of heaven and earth to help people's health" According to the reporter, Lanyao Pharmaceutical Co., Ltd was founded in 1958 It is a wholly-owned subsidiary of Beijing haijixing Medical Technology Co., Ltd and a modern comprehensive pharmaceutical industry enterprise focusing on drug production and management, scientific research and development, and diversified operation Now we produce more than 450 kinds and specifications of tablet, capsule, granule and small volume injection In 2013, in response to the plan of Gansu provincial Party committee and government to go out of the city and enter the park, the company moved from xiaogouping in Chengguan District to Zhongbang Avenue in Anning District The production facilities and equipment were greatly improved, the product quality was steadily improved, and the sales market was expanding day by day In the process of the company's great stride, in 2014, with the approval of Gansu Development and Reform Commission, the company acquired 280 mu of land in Lanzhou New Area and invested in the construction of a large-scale pharmaceutical enterprise with advanced equipment management modernization The formal production of the new area production base has become a node sign for Gansu to revitalize the real economy and go out of the city to enter the park The new area production base of Lanzhou Pharmaceutical Co., Ltd is constructed in two phases, with a total construction area of 3651181m2 and an investment of 630 million The second phase will invest in the construction of "industrial demonstration project of anti-tumor drugs and auxiliary drugs", with a planned investment of 406 million yuan and a construction area of 22000 m2.